Abstract
An adverse event is any untoward medical occurrence in a patient or subject administered a pharmaceutical product, treated with a research device, or involved in a research procedure. A serious adverse event is one that results in death, is life-threatening, requires hospitalization, results in a persistent or significant disability or incapacity, and results in a congenital anomaly or birth defect, or other serious conditions, such as a new cancer. All adverse events and serious events must be reported to the sponsor and the IRB, although some may be reported instead as endpoints, as decided by the sponsor. A protocol deviation is any change, divergence, or departure from the approved study design or procedures of a research protocol that has not been approved by the IRB.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
East, C. (2018). Adverse Events and Protocol Deviations. In: Developing a Successful Clinical Research Program. Springer, Cham. https://doi.org/10.1007/978-3-319-54693-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-54693-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54692-6
Online ISBN: 978-3-319-54693-3
eBook Packages: MedicineMedicine (R0)